摩根中国生物医药混合(QDII)C(019573) - 基金对比
最后更新于：2026-09-10
非全收益率指数点位的计算不包含分红再投入，所以理论上指数基金的分红再投入收益率高于其对应的指数点位涨幅。
加载中......
| 日期 | 摩根中国生物医药混合(QDII)C - 相对起始点分红再投入收益率 | 沪深300 - 相对起始点收益率 |
|---|---|---|
| 2026-09-10 | 57.12% | 43.44% |
| 2026-09-09 | 59.61% | 44.20% |
| 2026-09-08 | 62.42% | 43.76% |
| 2026-09-07 | 62.99% | 44.28% |
| 2026-09-04 | 64.09% | 43.43% |
| 2026-09-03 | 64.35% | 43.57% |
| 2026-09-02 | 62.41% | 43.42% |
| 2026-09-01 | 61.68% | 45.42% |
| 2026-08-31 | 63.37% | 45.86% |
| 2026-08-28 | 67.05% | 45.35% |
| 2026-08-27 | 68.49% | 46.02% |
| 2026-08-26 | 67.81% | 44.77% |
| 2026-08-25 | 66.06% | 43.55% |
| 2026-08-24 | 62.36% | 43.90% |
| 2026-08-21 | 68.47% | 45.66% |
| 2026-08-20 | 71.25% | 44.84% |
| 2026-08-19 | 65.06% | 44.71% |
| 2026-08-18 | 67.94% | 49.03% |
| 2026-08-17 | 68.30% | 49.51% |
| 2026-08-14 | 65.85% | 47.14% |
| 2026-08-13 | 67.30% | 47.08% |
| 2026-08-12 | 66.84% | 47.93% |
| 2026-08-11 | 67.56% | 47.08% |
| 2026-08-10 | 66.22% | 48.28% |
| 2026-08-07 | 65.25% | 48.04% |
| 2026-08-06 | 56.85% | 46.68% |
| 2026-08-05 | 56.97% | 46.90% |
| 2026-08-04 | 53.97% | 45.09% |
| 2026-08-03 | 50.33% | 43.27% |
| 2026-07-31 | 54.31% | 44.69% |
| 2026-07-30 | 52.68% | 43.48% |
| 2026-07-29 | 57.76% | 45.07% |
| 2026-07-28 | 58.34% | 44.10% |
| 2026-07-27 | 63.16% | 48.29% |
| 2026-07-24 | 61.38% | 46.62% |
| 2026-07-23 | 66.71% | 49.10% |
| 2026-07-22 | 66.62% | 48.76% |
| 2026-07-21 | 66.74% | 49.45% |
| 2026-07-20 | 64.62% | 45.01% |
| 2026-07-17 | 58.41% | 42.83% |
| 2026-07-16 | 68.46% | 48.17% |
| 2026-07-15 | 69.23% | 50.95% |
| 2026-07-14 | 63.70% | 51.26% |
| 2026-07-13 | 59.82% | 48.07% |
| 2026-07-10 | 62.05% | 50.77% |
| 2026-07-09 | 58.83% | 53.78% |
| 2026-07-08 | 56.57% | 49.97% |
| 2026-07-07 | 59.07% | 51.13% |
| 2026-07-06 | 66.43% | 52.70% |
| 2026-07-03 | 65.64% | 52.70% |